CZR

Caesars Entertainment, Inc.

52
Fundamentals46/ 100
Valuation50/ 100
Upside potential56/ 100
Risk potential21/ 100

CZR has a slight edge over F overall, supported by stronger fundamentals and lower modeled downside.

F

Ford Motor Company

52
Fundamentals40/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential23/ 100

F offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

CZR Fundamentals

MetricStatus
Stable
Under pressure
Healthy
Under pressure

CZR's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.

F Fundamentals

MetricStatus
Stable
Under pressure
Under pressure
Strong

F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.

CZR PE Valuation

CZR has no meaningful PE right now: it lost money over the past year.

F PE Valuation

F has no meaningful PE right now: it lost money over the past year.

CZR Forward outlook

MetricOutlook
--
Losses growing
Stable
Weakening
Limited
Low

Analysts expect CZR's losses to grow, with revenue holding steady. However, they disagree widely on these estimates.

F Forward outlook

MetricOutlook
--
Strong growth
Stable
Improving
Limited
Low

F has the edge over CZR on the outlook, with more favorable earnings and profitability expectations.

CZR Risk to reward

ScenarioChangePrice
Upside+27%$37.12
Downside-21%$23.14

Calculated from the latest close: $29.28 on Nov 12.

CZR trails F on modeled risk to reward, with less potential upside relative to its potential downside.

F Risk to reward

ScenarioChangePrice
Upside+31%$15.58
Downside-23%$9.16

Calculated from the latest close: $11.90 on Nov 12.

F has a better modeled risk to reward balance than CZR, with more potential upside relative to its potential downside.

CZR Earnings Per Share

Q4 2023: $3.64Q1 2024: $3.54Q2 2024: $-1.28Q3 2024: $-1.66Q4 2024: $-1.29Q1 2025: $-1.10Q2 2025: $-0.93Q3 2025: $-1.16Q4 2025: $-2.42Q1 2026: $-2.36Q2 2026: $-2.27Q3 2026: $-2.61
Q4 2023: $3.64Q1 2024: $3.54Q2 2024: $-1.28Q3 2024: $-1.66Q4 2024: $-1.29Q1 2025: $-1.10Q2 2025: $-0.93Q3 2025: $-1.16Q4 2025: $-2.42Q1 2026: $-2.36Q2 2026: $-2.27Q3 2026: $-2.61
QuarterTTM EPSYoY
Q3 2026-$2.61-$1.45
Q2 2026-$2.27-$1.34
Q1 2026-$2.36-$1.26
Q4 2025-$2.42-$1.13
Q3 2025-$1.16+$0.50
Q2 2025-$0.93+$0.35
Q1 2025-$1.10-131%
Q4 2024-$1.29-135%

CZR is still losing money, but far less than before: $2.61 per share over the past year, against $13.50 at its worst in late 2020.

F Earnings Per Share

Q4 2023: $1.08Q1 2024: $0.97Q2 2024: $0.96Q3 2024: $0.88Q4 2024: $1.46Q1 2025: $1.25Q2 2025: $0.78Q3 2025: $1.16Q4 2025: $-2.06Q1 2026: $-1.55Q2 2026: $-1.87Q3 2026: $-1.97Forward: $1.78
Q4 2023: $1.08Q1 2024: $0.97Q2 2024: $0.96Q3 2024: $0.88Q4 2024: $1.46Q1 2025: $1.25Q2 2025: $0.78Q3 2025: $1.16Q4 2025: $-2.06Q1 2026: $-1.55Q2 2026: $-1.87Q3 2026: $-1.97Forward: $1.78
QuarterTTM EPSYoY
Forward$1.78—
Q3 2026-$1.97-270%
Q2 2026-$1.87-340%
Q1 2026-$1.55-224%
Q4 2025-$2.06-241%
Q3 2025$1.16+32%
Q2 2025$0.78-19%
Q1 2025$1.25+29%
Q4 2024$1.46+35%

F has the edge over CZR on earnings, with more consistent year-over-year improvement.

CZR Quarterly Revenue

Q4 2023: $2.8BQ1 2024: $2.7BQ2 2024: $2.8BQ3 2024: $2.9BQ4 2024: $2.8BQ1 2025: $2.8BQ2 2025: $2.9BQ3 2025: $2.9BQ4 2025: $2.9BQ1 2026: $2.9BQ2 2026: $3BQ3 2026: $2.9B
Q4 2023: $2.8BQ1 2024: $2.7BQ2 2024: $2.8BQ3 2024: $2.9BQ4 2024: $2.8BQ1 2025: $2.8BQ2 2025: $2.9BQ3 2025: $2.9BQ4 2025: $2.9BQ1 2026: $2.9BQ2 2026: $3BQ3 2026: $2.9B
QuarterRevenueYoY
Q3 2026$2.9B+2.5%
Q2 2026$3B+3%
Q1 2026$2.9B+2.7%
Q4 2025$2.9B+4.2%
Q3 2025$2.9B-0.2%
Q2 2025$2.9B+2.7%
Q1 2025$2.8B+1.9%
Q4 2024$2.8B-0.9%

CZR has the edge over F on sales, with more consistent year-over-year improvement.

F Quarterly Revenue

Q4 2023: $46BQ1 2024: $42.8BQ2 2024: $47.8BQ3 2024: $46.2BQ4 2024: $48.2BQ1 2025: $40.7BQ2 2025: $50.2BQ3 2025: $50.5BQ4 2025: $45.9BQ1 2026: $43.3BQ2 2026: $48.3BQ3 2026: $49.5B
Q4 2023: $46BQ1 2024: $42.8BQ2 2024: $47.8BQ3 2024: $46.2BQ4 2024: $48.2BQ1 2025: $40.7BQ2 2025: $50.2BQ3 2025: $50.5BQ4 2025: $45.9BQ1 2026: $43.3BQ2 2026: $48.3BQ3 2026: $49.5B
QuarterRevenueYoY
Q3 2026$49.5B-2%
Q2 2026$48.3B-3.8%
Q1 2026$43.3B+6.4%
Q4 2025$45.9B-4.8%
Q3 2025$50.5B+9.4%
Q2 2025$50.2B+5%
Q1 2025$40.7B-5%
Q4 2024$48.2B+4.9%

F's revenue grew through 2023 and has held roughly level since: $49.5B last quarter, down 2% from the same quarter a year ago.

CZR Free Cash Flow

Q4 2023: $139MQ1 2024: −$184MQ2 2024: $125MQ3 2024: −$192MQ4 2024: $30MQ1 2025: −$5MQ2 2025: $232MQ3 2025: $123MQ4 2025: $147MQ1 2026: $36MQ2 2026: $304MQ3 2026: $95M
Q4 2023: $139MQ1 2024: −$184MQ2 2024: $125MQ3 2024: −$192MQ4 2024: $30MQ1 2025: −$5MQ2 2025: $232MQ3 2025: $123MQ4 2025: $147MQ1 2026: $36MQ2 2026: $304MQ3 2026: $95M
QuarterFree cash flowYoY
Q3 2026$95M-23%
Q2 2026$304M+31%
Q1 2026$36M+$41M
Q4 2025$147M+390%
Q3 2025$123M+$315M
Q2 2025$232M+86%
Q1 2025-$5M+$179M
Q4 2024$30M-78%

CZR has the edge over F on cash flow, with more consistent year-over-year improvement.

F Free Cash Flow

Q4 2023: $197MQ1 2024: −$709MQ2 2024: $3.4BQ3 2024: $3.5BQ4 2024: $530MQ1 2025: $1.9BQ2 2025: $4.2BQ3 2025: $5.3BQ4 2025: $1.1BQ1 2026: −$1.1BQ2 2026: $2BQ3 2026: $3.1B
Q4 2023: $197MQ1 2024: −$709MQ2 2024: $3.4BQ3 2024: $3.5BQ4 2024: $530MQ1 2025: $1.9BQ2 2025: $4.2BQ3 2025: $5.3BQ4 2025: $1.1BQ1 2026: −$1.1BQ2 2026: $2BQ3 2026: $3.1B
QuarterFree cash flowYoY
Q3 2026$3.1B-40%
Q2 2026$2B-54%
Q1 2026-$1.1B-157%
Q4 2025$1.1B+108%
Q3 2025$5.3B+50%
Q2 2025$4.2B+24%
Q1 2025$1.9B+$2.6B
Q4 2024$530M+169%

F still generates free cash flow, though less than at its 2020 peak: $5.1B over the past year.

CZR Total Shares

Q4 2023: 216MQ1 2024: 216MQ2 2024: 216MQ3 2024: 215MQ4 2024: 215MQ1 2025: 212MQ2 2025: 209MQ3 2025: 207MQ4 2025: 208MQ1 2026: 204MQ2 2026: 204MQ3 2026: 204M
Q4 2023: 216MQ1 2024: 216MQ2 2024: 216MQ3 2024: 215MQ4 2024: 215MQ1 2025: 212MQ2 2025: 209MQ3 2025: 207MQ4 2025: 208MQ1 2026: 204MQ2 2026: 204MQ3 2026: 204M
PeriodChange %Net change
Quarterly0%--
1 year-1.4%-3M shares
3 years-5.6%-12M shares
5 years-4.7%-10M shares
Available history+162%+126M shares

CZR has the edge over F on shareholder dilution, with a more favorable share count trend.

F Total Shares

Q4 2023: 4BQ1 2024: 4BQ2 2024: 4BQ3 2024: 4BQ4 2024: 4BQ1 2025: 4BQ2 2025: 4BQ3 2025: 4BQ4 2025: 4BQ1 2026: 4.1BQ2 2026: 4BQ3 2026: 4.1B
Q4 2023: 4BQ1 2024: 4BQ2 2024: 4BQ3 2024: 4BQ4 2024: 4BQ1 2025: 4BQ2 2025: 4BQ3 2025: 4BQ4 2025: 4BQ1 2026: 4.1BQ2 2026: 4BQ3 2026: 4.1B
PeriodChange %Net change
Quarterly+2.2%+89M shares
1 year+0.7%+28M shares
3 years+0.6%+26M shares
5 years+1%+40M shares
Available history+1.8%+72M shares

F has 4.1B diluted shares, up 0.7% from a year ago.

CZR Net Leverage

Q4 2023: 3.0xQ1 2024: 3.2xQ2 2024: 3.2xQ3 2024: 3.4xQ4 2024: 3.1xQ1 2025: 3.1xQ2 2025: 3.0xQ3 2025: 3.0xQ4 2025: 3.3xQ1 2026: 3.3xQ2 2026: 3.3xQ3 2026: 3.3x
Q4 2023: 3.0xQ1 2024: 3.2xQ2 2024: 3.2xQ3 2024: 3.4xQ4 2024: 3.1xQ1 2025: 3.1xQ2 2025: 3.0xQ3 2025: 3.0xQ4 2025: 3.3xQ1 2026: 3.3xQ2 2026: 3.3xQ3 2026: 3.3x
QuarterNet LeverageStatus
Q3 20263.3xElevated
Q2 20263.3xElevated
Q1 20263.3xElevated
Q4 20253.3xElevated
Q3 20253.0xElevated
Q2 20253.0xElevated
Q1 20253.1xElevated
Q4 20243.1xElevated

CZR's net debt is about 3.3 years of its operating earnings (EBITDA), up from 3.0 years a year ago.

F Net Leverage

Q4 2023: -1.9xQ1 2024: -1.6xQ2 2024: -1.7xQ3 2024: -2.1xQ4 2024: -1.8xQ1 2025: -1.8xQ2 2025: -2.2xQ3 2025: -2.4xQ4 2025: -3.4xQ1 2026: -2.0xQ2 2026: -2.1xQ3 2026: -2.5x
Q4 2023: -1.9xQ1 2024: -1.6xQ2 2024: -1.7xQ3 2024: -2.1xQ4 2024: -1.8xQ1 2025: -1.8xQ2 2025: -2.2xQ3 2025: -2.4xQ4 2025: -3.4xQ1 2026: -2.0xQ2 2026: -2.1xQ3 2026: -2.5x
QuarterNet LeverageStatus
Q3 2026-2.5xNet Cash
Q2 2026-2.1xNet Cash
Q1 2026-2.0xNet Cash
Q4 2025-3.4xNet Cash
Q3 2025-2.4xNet Cash
Q2 2025-2.2xNet Cash
Q1 2025-1.8xNet Cash
Q4 2024-1.8xNet Cash

F has the edge over CZR on leverage, with a lower net debt burden relative to earnings.

CZR Weekly Momentum

MetricValueStatus
RSI54.5Neutral
Stochastic38.6Neutral

CZR's weekly RSI is 55 (neutral) and its Stochastic is 39 (neutral).

F Weekly Momentum

MetricValueStatus
RSI41.5Neutral
Stochastic19.6Oversold

F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).

CZR PE vs Consumer Cyclical Sector

MetricCZRSector medianRelative
PEN/A18x—

CZR has no meaningful PE right now: it lost money over the past year.

F PE vs Consumer Cyclical Sector

MetricFSector medianRelative
PEN/A18x—

F has no meaningful PE right now: it lost money over the past year.

CZR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$29.20.1% above
20 week MA$29.61.1% below
50 week MA$27.37.2% above
100 week MA$27.66.3% above
200 week MA$35.718% below

CZR has the edge over F on trend strength, trading above more of its moving averages.

F Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.22.5% below
20 week MA$13.311% below
50 week MA$13.411% below
100 week MA$12.12% below
200 week MA$12.11.4% below

F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.

CZR Yearly ROI

YearStart priceEnd priceROI
2020$59.2$75.8+28%
2021$75.8$94.8+25%
2022$94.8$43.1-55%
2023$43.1$46.9+8.8%
2024$46.9$33.1-29%
2025$33.1$24.8-25%
2026 YTD$24.8$29.3+18%

CZR has the edge over F on returns for 2026, with the stronger performance.

F Yearly ROI

YearStart priceEnd priceROI
2020$9.36$8.86-5.3%
2021$8.86$20.3+129%
2022$20.3$11.4-44%
2023$11.4$12.2+7.3%
2024$12.2$10.0-18%
2025$10.0$13.3+33%
2026 YTD$13.3$11.9-11%

F's yearly returns have swung widely, from +129% in 2021 to −44% in 2022. It's down 11% so far in 2026.

Give your agent the market.

Get API key